Your browser doesn't support javascript.
loading
SYK-mediated epithelial cell state is associated with response to c-Met inhibitors in c-Met-overexpressing lung cancer.
Zhou, Ji; Zhang, Xu-Chao; Xue, Shan; Dai, Mengdi; Wang, Yueliang; Peng, Xia; Chen, Jianjiao; Wang, Xinyi; Shen, Yanyan; Qin, Hui; Chen, Bi; Zheng, Yu; Gao, Xiwen; Xie, Zuoquan; Ding, Jian; Jiang, Handong; Wu, Yi-Long; Geng, Meiyu; Ai, Jing.
Afiliação
  • Zhou J; Division of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Zhang XC; University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing, 100049, China.
  • Xue S; Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, and Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, 510080, China.
  • Dai M; Department of Respiratory Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China.
  • Wang Y; Division of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Peng X; University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing, 100049, China.
  • Chen J; Division of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Wang X; Division of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Shen Y; Department of Neurobiology, Brain Institute, University of Pittsburgh, Pittsburgh, 15213, USA.
  • Qin H; Division of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Chen B; Division of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Zheng Y; Department of Respiratory Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China.
  • Gao X; Department of Respiratory Medicine, Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221000, China.
  • Xie Z; Department of Respiratory Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China.
  • Ding J; Department of Respiratory Medicine, Minhang Hospital, Fudan University, Shanghai, 201199, China.
  • Jiang H; Division of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Wu YL; University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing, 100049, China.
  • Geng M; Division of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Ai J; University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing, 100049, China.
Signal Transduct Target Ther ; 8(1): 185, 2023 05 15.
Article em En | MEDLINE | ID: mdl-37183231
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Idioma: En Ano de publicação: 2023 Tipo de documento: Article